Indications |
Oral Urine alkalinisation Adult: To prevent development of uric-acid renal calculi in the initial stages of uricosuric therapy for hyperuricaemia in chronic gout: Up to 10 g daily in divided doses, to be taken with a liberal amount of fluid. Elderly: Dosage adjustments may be required. Renal impairment: Dosage adjustments may be required. Hepatic impairment: Dosage adjustments may be required. Oral Chronic metabolic acidosis Adult: Doses providing 57 mmol (4.8 g sodium bicarbonate) or more daily as required. Elderly: Dosage adjustments may be required. Renal impairment: Dosage adjustments may be required. Hepatic impairment: Dosage adjustments may be required. Oral Dyspepsia Adult: 1-5 g in water, may be taken as required. Elderly: Dosage adjustments may be required. Renal impairment: Dosage adjustments may be required. Hepatic impairment: Dosage adjustments may be required. Intravenous Severe metabolic acidosis Adult: By slow inj of a hypertonic solution of up to 8.4% (1000 mmol/L), or by continuous infusion of a weaker solution, usually 1.26% (150 mmol/L). For correction of acidosis during advanced cardiac life support procedures, 50 ml of an 8.4% solution may be given. Elderly: Dosage adjustments may be required. Renal impairment: Dosage adjustments may be required. Hepatic impairment: Dosage adjustments may be required. |
Contraindications |
Metabolic or respiratory alkalosis; hypernatraemia, severe pulmonary oedema; hypocalcaemia, hypochlorhydria. |
Warnings / Precautions |
Epilepsy, CHF, renal impairment, liver cirrhosis, hypertension, oedema, eclampsia, aldosteronism. Monitor serum electrolyte concentrations and acid-base status regularly during treatment of acidosis. Pregnancy; lactation. |
Adverse Reactions |
Metabolic alkalosis; mood changes, tiredness, shortness of breath, muscle weakness, irregular heartbeat; muscle hypertonicity, twitching, tetany; hypernatraemia, hyperosmolality, hypocalcaemia, hypokalaemia; stomach cramps, flatulence. Tissue necrosis at inj site. |
Drug Interactions |
Increases toxicity of amphetamines, ephedrine, pseudoephedrine, flecainide, quinidine and quinine. Decreases effects of lithium, chlorpropamide and salicylates due to increased clearance. May affect the absorption of certain drugs due to raised intra-gastric pH. See Below for More sodium bicarbonate Drug Interactions |
Mechanism of Actions |
Sodium bicarbonate raises blood and urinary pH by dissociation to provide bicarbonate ions, which neutralises the hydrogen ion concentration. It also neutralises gastric acid via production of carbon dioxide. Onset: Oral: Rapid; IV: 15 minutes. Duration: Oral: 8-10 minutes; IV: 1-2 hr. |
Administration |
Should be taken on an empty stomach (i.e. At least one hour before food or two hours after food). |
ATC Classification |
B05CB04 - sodium bicarbonate ; Belongs to the class of salt solutions used as irrigating solutions. B05XA02 - sodium bicarbonate ; Belongs to the class of electrolyte solutions used in I.V. solutions. |
Available As |
|
Sodium Bicarbonate
Post Review about Sodium Bicarbonate Click here to cancel reply.
Sodium Bicarbonate Containing Brands
Sodium Bicarbonate is used in following diseases
Drug - Drug Interactions of Sodium Bicarbonate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.